MDT Medtronic
- 84.510
- -1.410-1.64%
Medtronic News
Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
On Friday, Medtronic plc (NYSE:MDT) released results from the SPHERE Per-AF study comparing Sphere-9 to the conventional Thermocool SmartTouch SF radiofrequency ablation catheter with the Carto 3 Syst
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
EuroPCR: Medtronic Evolut TAVR Platform Demonstrates Improved Quality of Life for Women With Severe Aortic Stenosis
Assessing Medtronic's Market Position in the Evolving Electrophysiology Landscape
Wells Fargo Sticks to Their Buy Rating for Medtronic (MDT)
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses.
Medtronic Study of Affera Sphere-9 Catheter Meets Endpoints
Medtronic Trial for AFib System Achieves Endpoints
Medtronic said its combined system for use during treatment of atrial fibrillation reached its safety and efficacy endpoints in a trial.
Express News | Medtronic Affera™ Mapping and Ablation System With Sphere-9™ Catheter Achieves Endpoints for Safety and Efficacy, Providing Promising Evidence for the Future of Atrial Fibrillation Treatment
Medtronic Stock Trades up for the Seventh Straight Session
Medtronic Data Shows Safety and Efficacy of Affera, Sphere-9 All-in-one Ablation
Medtronic Unusual Options Activity
Financial giants have made a conspicuous bullish move on Medtronic. Our analysis of options history for Medtronic (NYSE:MDT) revealed 23 unusual trades.Delving into the details, we found 47% of trader
Express News | NYSE Order Imbalance 286382.0 Shares on Sell Side
Medtronic's Investigational Defibrillation Lead Meets Primary Study Endpoints
Express News | Late-Breaking Data Show Reliable Performance of Small-Diameter Defibrillation Lead, the Medtronic Omniasecure™
Investors Heavily Search Medtronic PLC (MDT): Here Is What You Need to Know
Stocks to Watch Next Week: Nvidia, Marks & Spencer, Ryanair and UK Inflation
Late-breaking Data Show Reliable Performance of Small-diameter Defibrillation Lead, the Medtronic OmniaSecure
Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart RhythmDUBLIN and BOSTON, May 17, 2024 /PRNewswire(op
Medtronic Affera Mapping and Ablation System With Sphere-9 Catheter Achieves Endpoints for Safety and Efficacy, Providing Promising Evidence for the Future of Atrial Fibrillation Treatment
HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of lifeDUBLIN and BOSTON, May 17, 2024 /PR
Analysis
Price Target
No Data
